Suraksha Diagnostic IPO subscribed 25% on Day 2 led by retail segment; check GMP, other details

Ganesh Infraworld, a prominent player in construction and allied services, has opened its initial public offering with a price band set at Rs 78-83 per share.

Suraksha Diagnostic initial public offer (IPO) was subscribed 25 percent on the second day of share sale on December 2.

The maiden share sale received bids for 34 lakh shares against 1.34 crore shares on offer.

The retail individual investors (RIIs) part got subscribed 45 percent and non-institutional investors category received 13 percent subscription, while qualified institutional buyers picked 1,326 shares against their reserved portion of 38.37 lakh shares.

According to market observers, the shares of Suraksha Diagnostic are commanding a flat grey market premium.

The shares of the company are likely to be allotted on 4th December, while the shares will be listed on the exchanges on Friday, 6th December.

Suraksha Diagnostic IPO sees muted response on day 1, subscribed 11% with no bids from QIBs

Integrated diagnostic chain Suraksha Diagnostic Ltd on Thursday said it has mobilised Rs 254 crore from anchor investors.

The Rs 846-crore initial share sale will conclude on December 3. The shares are available in the price range of Rs 420 to Rs 441 apiece.

The Kolkata-based company's IPO comprises a complete Offer for Sale (OFS) of 19,189,330 equity shares valued at Rs 846.25 crore, based on the upper price band. The shares will be offloaded by the promoters and investor shareholders, with no fresh issue involved.

As part of the OFS, promoters Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma, along with investors OrbiMed Asia II Mauritius Ltd, Munna Lal Kejriwal, and Santosh Kumar Kejriwal, will divest their holdings.

Since the IPO is entirely an OFS, the company itself will not receive any funds. The entire proceeds will go directly to the selling shareholders.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.